Stratification subgroup analysis of overall survival with darolutamide versus placebo in combination with androgen-deprivation therapy and docetaxel in the phase 3 ARASENS trial
Bertrand Tombal, Maha Hussain, Fred Saad, Karim Fizazi, Cora N. Sternberg, E David Crawford, Evgeny Kopyltsov, Arash Rezazadeh Kalebasty, Boris Alekseev, Álvaro Montesa-Pino, Dingwei Ye, Francis Parnis, Cruz Felipe Melo, Teuvo Tammela, Hiroyoshi Suzuki, Heikki Joensuu, Silke Thiele, Rui Li, Iris Kuss
Tutkimustuotos: Abstrakti › Scientific
Sormenjälki
Sukella tutkimusaiheisiin 'Stratification subgroup analysis of overall survival with darolutamide versus placebo in combination with androgen-deprivation therapy and docetaxel in the phase 3 ARASENS trial'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.